Quantitative analysis for Sagimet Biosciences Inc. (SGMT) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Buy (87.0) (grade A). 29 signals analyzed (23 differentiated alt-data).
SGMT stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $8.78 | $7.95 | $8.60 |
| 2026-05-11 | $7.91 | $7.58 | $7.69 |
| 2026-05-21 | $7.26 | $6.50 | $7.00 |
| 2026-06-03 | $6.88 | $6.60 | $6.86 |
| 2026-06-15 | $6.71 | $6.45 | $6.47 |
| 2026-06-26 | $7.15 | $6.80 | $7.06 |
| 2026-07-09 | $7.46 | $7.20 | $7.35 |
| 2026-07-21 | $7.22 | $7.00 | $7.07 |
| 2026-07-31 | $7.33 | $6.88 | $7.11 |
| 2026-08-12 | $9.85 | $9.38 | $9.39 |
| 2026-08-24 | $10.51 | $9.96 | $10.21 |
| 2026-09-03 | $11.24 | $10.62 | $10.92 |
How Sagimet Biosciences Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| HELP | Cybin Inc. Common Stock | $217M | — |
| EPRX | Eupraxia Pharmaceuticals Inc. | $213M | 63.0 |
| HITI | High Tide Inc. | $212M | — |
| WHWK | Whitehawk Therapeutics Inc | $209M | — |
View all Health Care stocks by valuation and signals →
Sagimet Biosciences Inc. (SGMT) scores Strong Buy (87.0), with no measured dimension below 51. Its highest are analyst consensus at 99, competitive moat at 87, valuation at 72, across 5 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| analyst consensus | 99 |
| competitive moat | 87 |
| valuation | 72 |
| technicals | 65 |
| earnings quality | 51 |
StoQuant analyzes 29 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Sagimet Biosciences Inc. (SGMT): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/SGMT"><img src="https://stoquant.com/badge/SGMT.svg" alt="Sagimet Biosciences Inc. (SGMT) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.